The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Naviswiss sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Naviswiss is a provider of technological platforms for orthopaedic surgeries. The company offers tracking and navigation systems for orthopedic surgeries, streamlining workflows and reducing the time and cost associated with surgical procedures. The company’s products are majorly used in hip surgeries. Its major technology platforms are Naviswiss Hip, Naviswiss HIP CT, and Naviplan. Naviswiss is headquartered in Brugg, Aargau, Switzerland.
The key metrics of Naviswiss related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Naviswiss is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Naviswiss.
For a detailed understanding of the performance of Naviswiss, buy the report here.